Tatva Chintan Pharma Chem share news, announcements and annual reports
NSE: TATVABSE: 543321Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,643.90.
2 Nov: open ₹1,645.00, high ₹1,691.90, low ₹1,579.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,887 Cr999th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 61.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.77
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 58,16834.6% delivered
Tatva Chintan Pharma Chem share news and announcements
329 announcements, routine notices left out, newest first. Page 3 of 7.
Jan 2025
17 Jan · Board meeting
Dec 2024
4 Dec · Analysts
Nov 2024
6 Nov · Rating
Oct 2024
25 Oct · Board meeting
25 Oct · Results
16 Oct · Analysts
16 Oct · Board meeting
Sep 2024
25 Sep · Legal
The exchange asked on 24 Sep 2024
23 Sep · Analysts
20 Sep · Meeting
4 Sep · Analysts
Aug 2024
24 Aug · Corporate action
8 Aug · Analysts
Jul 2024
24 Jul · Board meeting
24 Jul · Results
20 Jul · Analysts
16 Jul · Board meeting
Jun 2024
22 Jun · Analysts
10 Jun · Analysts
May 2024
3 May · Business
3 May · Dividend
3 May · Results
Apr 2024
27 Apr · Analysts
Mar 2024
26 Mar · Analysts
19 Mar · Analysts
16 Mar · Analysts
Feb 2024
9 Feb · Analysts
5 Feb · Analysts
2 Feb · Analysts
Jan 2024
27 Jan · Updates
23 Jan · Business
23 Jan · Business
20 Jan · Board meeting
20 Jan · Results